Status:
COMPLETED
Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel (MCAT)
Lead Sponsor:
Necmettin Erbakan University
Conditions:
Gingival Recession
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study investigates the treatment of gingival recession (specifically Miller Class I and II defects) using a minimally invasive surgical approach known as the modified coronally advanced tunnel (M...
Detailed Description
This randomized controlled clinical trial aims to evaluate both the short- and long-term clinical outcomes of the modified coronally advanced tunnel (MCAT) technique combined with various biomaterials...
Eligibility Criteria
Inclusion
- Adults aged between 18 and 60 years
- Systemically and periodontally healthy individuals
- Non-smokers
- Presence of a clearly detectable cementoenamel junction (CEJ)
- No prior surgical intervention at the selected sites
- No periodontal pockets deeper than 3 mm
- No signs of occlusal trauma
Exclusion
- Pregnancy or lactation
- Use of antibiotics in the past 6 months
- Presence of any systemic condition that may contraindicate periodontal surgery, including:
- Diabetes mellitus
- Impaired glucose tolerance
- Endocrine disorders
- Cardiovascular diseases
- Declined to participate or failed to meet inclusion criteria
Key Trial Info
Start Date :
January 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06504329
Start Date
January 24 2024
End Date
January 24 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necmettin Erbakan University, Faculty of Dentistry
Konya, Turkey (Türkiye)